Avelumab With Valproic Acid in Virus-associated Cancer
Clinical trial NCT03357757 · COMPLETED
Trial details
- NCT number
- NCT03357757
- Sponsor
- AHS Cancer Control Alberta
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-07
- Primary completion
- 2022-03-30
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.